XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Unaudited Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income $ 318,913 $ 335,774
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 19,893 16,615
Share-based compensation 16,517 13,529
Non-cash contribution to 401(k) plan 8,735 8,862
Provision for doubtful accounts 1,569 1,405
Deferred income tax provision 3,568 3,442
Other income from investment in unconsolidated entity (13,532) (10,878)
Other, net 294 (481)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable, net (203,962) (243,440)
Inventories, net (225,984) (313,634)
Accounts payable and other liabilities 233,517 103,442
Other, net 1,913 (3,815)
Net cash provided by (used in) operating activities 161,441 (89,179)
Cash flows from investing activities:    
Purchases of short-term cash investments (200,000) 0
Capital expenditures (12,262) (15,831)
Business acquisitions, net of cash acquired (5,173) (2,989)
Proceeds from sale of property and equipment 120 1,232
Net cash used in investing activities (217,315) (17,588)
Cash flows from financing activities:    
Net proceeds from the sale of Common stock 281,784 15,179
Net proceeds from issuances of Common stock under employee-related plans 17,103 13,827
Net proceeds from Dividend Reinvestment Plan 1 0
Payment of fees related to revolving credit agreement 0 (580)
Net repayments under prior revolving credit agreement 0 (56,400)
Repurchases of common stock to satisfy employee withholding tax obligations (1,209) (2,254)
Net repayments of finance lease liabilities (2,901) (1,795)
Net (repayments) proceeds under current revolving credit agreement (15,400) 342,900
Dividends on Common and Class B common stock (205,568) (190,409)
Net cash provided by financing activities 73,810 120,468
Effect of foreign exchange rate changes on cash and cash equivalents (3,194) 1,320
Net increase in cash and cash equivalents 14,742 15,021
Cash and cash equivalents at beginning of period 210,112 147,505
Cash and cash equivalents at end of period 224,854 162,526
Supplemental cash flow information:    
Common stock issued for Commercial Specialists, Inc. $ 752 $ 0